Studies related to Chemotaxis and Rose Hip

Rose Hip Inhibits Chemotaxis And Chemiluminescence Of Human Peripheral Blood Neutrophils In Vitro And Reduces Certain Inflammatory Parameters In Vivo

Effect Decrease
Trial Design Cohort
Trial Length 1-6 months
Number of Subjects 13
Gender Both Genders
Age Range 30-44, 45-64
Body Types Average
Notes for this study:
Rose hip supplementation at 10g (low dose) or 45g (high dose) in otherwise healthy persons appeared to reduce C-reactive protein by 20-40% at the higher dose and also reduced creatinine concentrations. There was no observed effect on other parameters measured aside from chemotaxis, which was reduced by over 50% in 12/13 persons.

The Anti-inflammatory Properties Of Rose-hip

Effect Decrease
Trial Design Cohort
Trial Length 1-6 months
Number of Subjects 8
Gender Male
Age Range 18-29, 30-44
Notes for this study:
Supplementation of either 10g or 45g rose hip powder extract to otherwise healthy men for one month was able to reduce C-reactive protein concentrations (up to 30-35%) and reduced chemotaxis of polymorphonuclear leukocytes by up to 50% (low dose) and 65% (high dose). It was also noted in four of the persons characterized by high physical work (due to their occupation) that rosehip alleviated joint discomfort.

All changes returned to baseline values after cessation of rosehip supplementation.